Skip to main content
Grant Details

Grant Number: 5R01CA244673-03 Interpret this number
Primary Investigator: Ferguson, Robert
Organization: University Of Pittsburgh At Pittsburgh
Project Title: Mobile Device Cbt for Chemotherapy-Related Cognitive Dysfunction: a Multi-Center Randomized Controlled Trial
Fiscal Year: 2022


ABSTRACT The proposed research will examine the efficacy of a videoconference-delivered cognitive-behavioral therapy (CBT), Memory and Attention Adaptation Training (MAAT), in a large, multi-site, randomized controlled trial (RCT) for breast cancer survivors with chemotherapy-related cognitive dysfunction (CRCD). Outcome measures include assessment of both subjective and objective cognitive functioning. Another goal of the research is to use functional MRI (fMRI) to evaluate underlying changes in brain activation patterns that are believed to be associated with positive effects of MAAT. Recent analyses by the MPIs have demonstrated enhanced working memory-related cortical activation following MAAT treatment among individuals with traumatic brain injury (TBI). The present work seeks to determine if the same activation patterns occur post- treatment with MAAT vs. an attention control condition (supportive therapy; ST) in breast cancer survivors. If successful, the results of this work will: (1) produce an evidence-based treatment that can be immediately disseminated to cancer centers and other healthcare settings to treat CRCD and (2) help inform further treatment development through improved understanding of mechanisms that promote CRCD recovery. MAAT utilizes a non-drug, CBT approach to enhance self-management, behavioral adaptation, and coping with late cognitive effects of chemotherapy. MAAT has been evaluated in four previous small trials: 1) a single-group pilot study (NCI R03); 2) a randomized waitlist control trial (Lance Armstrong Foundation); 3) and a randomized trial with an active control group condition (supportive therapy; ST) in which both MAAT and ST interventions were delivered via videoconference (NCI R21). Research with breast cancer survivors shows promising results with improved subjective and objective cognitive function. In a fourth trial, individuals with cognitive symptoms after traumatic brain injury (TBI) showed improved cognitive function when treated with MAAT alone or in combination with methylphenidate relative to those receiving behavioral or pill placebo. While research to date is favorable, MAAT has not been evaluated in a large RCT with independent, multiple clinicians or at multiple sites to establish efficacy and generalizability in the breast cancer population. Only one clinician has delivered MAAT in previous breast cancer survivorship studies and the sample sizes were small. Therefore, the proposed study makes important methodological improvements using a larger sample size in a multi-site, multi-clinician RCT with an ST control condition, and reduces survivorship travel burden by delivering both MAAT and ST over secured videoconference link. The proposed study therefore has the potential for great clinical and scientific impact, and will help offer effective non-pharmacologic treatment that can be widely disseminated using mobile technology, especially to rural survivors, to reduce travel and time burden and improve survivorship care.


Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.
Authors: Root J.C. , Zhou X. , Ahn J. , Small B.J. , Zhai W. , Bethea T. , Carroll J.E. , Cohen H.J. , Dilawari A. , Extermann M. , et al. .
Source: Breast cancer research and treatment, 2022 Jul; 194(2), p. 413-422.
EPub date: 2022-05-19.
PMID: 35587324
Related Citations

Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study.
Authors: Bethea T.N. , Zhai W. , Zhou X. , Ahles T.A. , Ahn J. , Cohen H.J. , Dilawari A.A. , Graham D.M.A. , Jim H.S.L. , McDonald B.C. , et al. .
Source: Cancer medicine, 2022-03-22; , .
EPub date: 2022-03-22.
PMID: 35315588
Related Citations

Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.
Authors: Small B.J. , Lange M. , Zhai W. , Ahn J. , Ahles T.A. , Carroll J.E. , Cohen H.J. , Graham D. , Extermann M. , Heutte N. , et al. .
Source: Breast cancer research and treatment, 2022 Jan; 191(2), p. 459-469.
EPub date: 2021-11-24.
PMID: 34817750
Related Citations

Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.
Authors: Rentscher K.E. , Zhou X. , Small B.J. , Cohen H.J. , Dilawari A.A. , Patel S.K. , Bethea T.N. , Van Dyk K.M. , Nakamura Z.M. , Ahn J. , et al. .
Source: Cancer, 2021-10-01; 127(19), p. 3671-3679.
EPub date: 2021-06-23.
PMID: 34161601
Related Citations

Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment.
Authors: Kesler S.R. , Sleurs C. , McDonald B.C. , Deprez S. , van der Plas E. , Nieman B.J. .
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021-06-01; 39(16), p. 1775-1785.
EPub date: 2021-04-22.
PMID: 33886371
Related Citations

Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction.
Authors: McDonald B.C. .
Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021 04; 18(2), p. 792-810.
EPub date: 2021-08-16.
PMID: 34402034
Related Citations

Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
Authors: Van Dyk K. , Zhou X. , Small B.J. , Ahn J. , Zhai W. , Ahles T. , Graham D. , Jacobsen P.B. , Jim H. , McDonald B.C. , et al. .
Source: JNCI cancer spectrum, 2021 04; 5(2), .
EPub date: 2021-01-27.
PMID: 33748669
Related Citations

Back to Top